company background image
600351 logo

Yabao Pharmaceutical Group SHSE:600351 Stock Report

Last Price

CN¥6.02

Market Cap

CN¥4.6b

7D

-4.9%

1Y

-13.6%

Updated

27 Mar, 2024

Data

Company Financials

Yabao Pharmaceutical Group Co., Ltd

SHSE:600351 Stock Report

Market Cap: CN¥4.6b

600351 Stock Overview

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally.

600351 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends3/6

Yabao Pharmaceutical Group Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Yabao Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥6.02
52 Week HighCN¥9.00
52 Week LowCN¥4.94
Beta0.28
1 Month Change-3.99%
3 Month Change-12.50%
1 Year Change-13.63%
3 Year Change22.86%
5 Year Change-26.76%
Change since IPO50.98%

Recent News & Updates

Recent updates

Shareholder Returns

600351CN PharmaceuticalsCN Market
7D-4.9%-3.4%-2.2%
1Y-13.6%-11.4%-14.8%

Return vs Industry: 600351 underperformed the CN Pharmaceuticals industry which returned -11.4% over the past year.

Return vs Market: 600351 exceeded the CN Market which returned -14.8% over the past year.

Price Volatility

Is 600351's price volatile compared to industry and market?
600351 volatility
600351 Average Weekly Movement6.5%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 600351 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600351's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19784,367Ren Weihttps://www.yabao.com.cn

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. The company provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.

Yabao Pharmaceutical Group Co., Ltd Fundamentals Summary

How do Yabao Pharmaceutical Group's earnings and revenue compare to its market cap?
600351 fundamental statistics
Market capCN¥4.63b
Earnings (TTM)CN¥211.62m
Revenue (TTM)CN¥2.94b

21.5x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600351 income statement (TTM)
RevenueCN¥2.94b
Cost of RevenueCN¥1.30b
Gross ProfitCN¥1.65b
Other ExpensesCN¥1.43b
EarningsCN¥211.62m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)0.28
Gross Margin55.90%
Net Profit Margin7.19%
Debt/Equity Ratio8.0%

How did 600351 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

18%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.